Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX Stocks Estimated To Be Trading At 35-44% Below Intrinsic Value

In This Article:

As the ASX200 closed up 0.69% at 8,126 points, sectors like IT and Real Estate led gains while Utilities and Energy lagged behind. In this fluctuating market environment, identifying undervalued stocks trading significantly below their intrinsic value can offer potential opportunities for investors looking to capitalize on market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In Australia

Name

Current Price

Fair Value (Est)

Discount (Est)

Acrow (ASX:ACF)

A$1.04

A$2.03

48.7%

Praemium (ASX:PPS)

A$0.745

A$1.24

39.7%

Champion Iron (ASX:CIA)

A$4.57

A$8.99

49.2%

Amaero (ASX:3DA)

A$0.25

A$0.47

46.4%

Pantoro Gold (ASX:PNR)

A$2.92

A$4.95

41%

Nuix (ASX:NXL)

A$2.43

A$4.22

42.5%

Integral Diagnostics (ASX:IDX)

A$2.42

A$4.10

41%

Electro Optic Systems Holdings (ASX:EOS)

A$1.225

A$2.34

47.7%

Sandfire Resources (ASX:SFR)

A$9.97

A$17.82

44%

Superloop (ASX:SLC)

A$2.50

A$4.58

45.4%

Click here to see the full list of 35 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.

Let's explore several standout options from the results in the screener.

Integral Diagnostics

Overview: Integral Diagnostics Limited is a healthcare services company that provides diagnostic imaging services to medical professionals and their patients in Australia and New Zealand, with a market cap of A$900.76 million.

Operations: The company's revenue is primarily derived from the operation of diagnostic imaging facilities, amounting to A$491.32 million.

Estimated Discount To Fair Value: 41%

Integral Diagnostics appears undervalued, trading at A$2.42, below its estimated fair value of A$4.1. Although its earnings are currently impacted by large one-off items, forecasts suggest significant annual profit growth of 40.6%, outpacing the Australian market's 11.7%. Despite past shareholder dilution and interest payments not well covered by earnings, the company's revenue growth is expected to surpass the market average at 16.4% annually, drawing private equity interest amid recent M&A rumors.

ASX:IDX Discounted Cash Flow as at Apr 2025
ASX:IDX Discounted Cash Flow as at Apr 2025

James Hardie Industries

Overview: James Hardie Industries plc manufactures and sells fiber cement, fiber gypsum, and cement bonded building products for construction applications in various regions including the United States, Australia, Europe, New Zealand, and the Philippines with a market cap of A$15.90 billion.

Operations: The company's revenue is primarily derived from its North America Fiber Cement segment at $2.88 billion, followed by Asia Pacific Fiber Cement at $543.30 million, and Europe Building Products at $488 million.